<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 17.2: PCOS in the Perimenopausal Transition | AccrediPro Academy</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text {
 flex: 1;
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: transparent;
 border: none;
 border-radius: 0;
 padding: 0;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #6b7280;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
 gap: 8px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 padding: 10px 14px;
 background: #f9fafb;
 border: none;
 border-radius: 8px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 background: #f3f4f6;
 color: #722F37;
 transform: translateX(4px);
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
 flex-shrink: 0;
}

/* WELCOME BOX */
.welcome-box {
 background: linear-gradient(135deg, #fefbf3 0%, #f8f5f0 100%);
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #B8860B;
 box-shadow: 0 4px 12px rgba(0, 0, 0, 0.04);
}

/* OBJECTIVES BOX */
.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

.objectives-box ul {
 list-style: none;
 margin: 0;
 padding: 0;
}

.objectives-box li {
 padding: 10px 0 10px 32px;
 position: relative;
 font-size: 16px;
 color: #4c1d95;
 border-bottom: 1px solid rgba(167, 139, 250, 0.2);
}

.objectives-box li::before {
 content: '‚úì';
 position: absolute;
 left: 0;
 color: #7c3aed;
 font-weight: 700;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

p {
 font-size: 17px;
 line-height: 1.85;
 color: #374151;
 margin-bottom: 20px;
}

.highlight {
 background: linear-gradient(120deg, #fef3c7 0%, #fef3c7 100%);
 padding: 1px 6px;
 border-radius: 4px;
 font-weight: 600;
 color: inherit;
}

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 6px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: linear-gradient(90deg, #722F37, #722F37);
 padding: 20px 28px;
}

.case-study-header .title {
 color: white;
 font-weight: 700;
 font-size: 18px;
 margin: 0;
}

.case-study-content {
 padding: 28px;
}

/* COACH TIP BOX */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.coach-tip .tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* INTERACTIVE COMPONENTS */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* KEY TAKEAWAYS BOX */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES BOX */
.references-box {
 background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 28px 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 color: #475569;
 margin-bottom: 8px;
}

/* MODULE CONNECTION BOX */
.module-connection {
 background: linear-gradient(135deg, #f0f9ff 0%, #e0f2fe 100%);
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.module-connection .connection-text {
 flex: 1;
}

.module-connection .connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
 line-height: 1.5;
}

 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 17: Complex Client Scenarios</span>
 <h1 class="lesson-title">Lesson 2: PCOS in the Perimenopausal Transition</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">üéì Lesson 2 of 8</span>
 <span class="meta-badge">üíé Premium Certification Content</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute Verified ‚Ä¢ PCOS & Metabolic Health Specialist‚Ñ¢</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <p class="toc-label">In This Lesson</p>
 <ul class="toc-list">
 <li><a href="#androgen-tail"><span class="section-num">01</span>The 'Androgen Tail' Flare</a></li>
 <li><a href="#metabolic-shift"><span class="section-num">02</span>Metabolic Shift Management</a></li>
 <li><a href="#hrt-alignment"><span class="section-num">03</span>HRT & Endocrine Alignment</a></li>
 <li><a href="#sarcopenia"><span class="section-num">04</span>Sarcopenia Prevention</a></li>
 <li><a href="#cardio-risk"><span class="section-num">05</span>Cardiovascular Risk Screening</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Building on Previous Learning:</strong> In Lesson 1, we explored the nuances of Lean PCOS. Now, we shift our focus to the aging client, where the intersection of <span class="highlight">ovarian senescence</span> and lifelong insulin resistance creates a unique metabolic storm that requires a specialized application of The S.T.E.A.D.Y. Method‚Ñ¢.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome, Specialist. For the woman with PCOS, the perimenopausal transition (the 2‚Äì10 years preceding menopause) is rarely a "winding down" of symptoms. Instead, it is often a period of significant <span class="highlight">metabolic and androgenic turbulence</span>. As estrogen and progesterone decline, the underlying PCOS architecture is often "unmasked," leading to weight gain, hair loss, and increased cardiovascular risk. This lesson equips you to guide clients through this transition with clinical precision and empathetic support.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Analyze the physiological mechanism of the "Androgen Tail" and its impact on symptom flares.</li>
 <li>Adapt Therapeutic Glucose Tuning (T) strategies to address the rapid increase in visceral adiposity.</li>
 <li>Evaluate Hormone Replacement Therapy (HRT) options through the lens of Endocrine System Alignment (E).</li>
 <li>Design sarcopenia prevention protocols using the Activity & Muscle Activation (A) framework.</li>
 <li>Identify advanced cardiovascular markers necessary for screening the aging PCOS population.</li>
 </ul>
 </div>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <p class="title">Case Study: The "Second Wave" of PCOS</p>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Linda, 49, former Registered Nurse pivoting to health coaching.</p>
 <p><strong>Presenting Symptoms:</strong> Linda‚Äôs PCOS had been "quiet" for a decade. However, in the last 18 months, she has gained 14 lbs (primarily in the midsection), developed cystic acne on her jawline for the first time since her 20s, and is experiencing debilitating night sweats and brain fog.</p>
 <p><strong>The Challenge:</strong> Linda felt like a "failure" because her previous diet and exercise habits were no longer working. She was over-exercising (cardio) and under-eating, which only exacerbated her cortisol-driven weight gain.</p>
 <p><strong>Intervention:</strong> By applying the S.T.E.A.D.Y. Method‚Ñ¢, we shifted her focus from calorie restriction to <span class="highlight">Therapeutic Glucose Tuning</span> and replaced her daily runs with heavy resistance training to combat sarcopenia. We also collaborated with her physician to introduce bioidentical progesterone.</p>
 <p><strong>Outcome:</strong> Linda lost 8 lbs of visceral fat, cleared her skin, and stabilized her energy, proving that the perimenopausal transition requires a strategy shift, not just "trying harder."</p>
 </div>
 </div>

 <h2 id="androgen-tail">The 'Androgen Tail': Why Symptoms Flare</h2>
 <p>In a neurotypical woman, perimenopause is defined by the gradual decline of all sex hormones. However, for the PCOS client, the decline is <span class="highlight">asymmetrical</span>. While estrogen and progesterone drop significantly, the ovaries and adrenal glands often continue to produce high levels of androgens‚Äîspecifically testosterone and androstenedione.</p>

 <p>This creates a phenomenon we call the <strong>"Androgen Tail."</strong> As the protective, "feminizing" effects of estrogen diminish, the relative ratio of androgens to estrogens increases. This can lead to:</p>
 <ul>
 <li><strong>Androgenic Alopecia:</strong> Thinning of the hair on the vertex of the scalp.</li>
 <li><strong>Hirsutism Flare:</strong> Increased terminal hair growth on the chin and upper lip.</li>
 <li><strong>Cystic Acne:</strong> Re-emergence of inflammatory lesions due to increased sebum production.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">üí° Practitioner Insight</span>
 <p>Clients often feel betrayed by their bodies during this time. As a specialist, you can earn $250-$500 per consultation by explaining this <em>relative androgen dominance</em>. It‚Äôs not that their PCOS is "getting worse," but that the hormonal "buffer" of estrogen is disappearing. This shift in perspective is the first step toward clinical success.</p>
 </div>

 <h2 id="metabolic-shift">Metabolic Shift & Therapeutic Glucose Tuning (T)</h2>
 <p>A 2022 meta-analysis confirmed that women with PCOS experience a more rapid increase in <strong>visceral adiposity</strong> (deep belly fat) during perimenopause compared to women without the condition. This is driven by the synergistic effect of estrogen deficiency and pre-existing insulin resistance.</p>

 <p>To manage this, we must adapt our <strong>Therapeutic Glucose Tuning (T)</strong> protocol. In our 40s and 50s, the "buffer" for high-glycemic errors shrinks. We must focus on:</p>

 <table class="data-table">
 <thead>
 <tr>
 <th>Focus Area</th>
 <th>Perimenopausal Adjustment</th>
 <th>Metabolic Goal</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td><strong>Protein Threshold</strong></td>
 <td>Increase to 1.2‚Äì1.5g/kg of body weight</td>
 <td>Protect lean mass & stimulate glucagon</td>
 </tr>
 <tr>
 <td><strong>Fiber Sequencing</strong></td>
 <td>10g of fiber <em>before</em> the largest meal</td>
 <td>Blunt the post-prandial insulin spike</td>
 </tr>
 <tr>
 <td><strong>Carbohydrate Timing</strong></td>
 <td>Consolidate complex carbs to post-workout</td>
 <td>Maximize non-insulin mediated glucose uptake</td>
 </tr>
 </tbody>
 </table>

 <h2 id="hrt-alignment">HRT & Endocrine System Alignment (E)</h2>
 <p>Hormone Replacement Therapy (HRT) is often the "missing piece" for the perimenopausal PCOS client. However, conventional HRT (synthetic progestins) can sometimes worsen androgenic symptoms. We focus on <strong>Endocrine System Alignment (E)</strong> by advocating for bioidentical options.</p>

 <p><strong>Bioidentical Progesterone (Prometrium):</strong> Unlike synthetic progestins (like medroxyprogesterone), bioidentical progesterone is chemically identical to what the body produces. It has a mild anti-androgenic effect and can significantly improve sleep and anxiety, which are critical for cortisol management.</p>

 <p><strong>Transdermal Estrogen:</strong> For PCOS clients, transdermal (patch/gel) estrogen is generally preferred over oral forms because it bypasses the liver and does not increase Sex Hormone Binding Globulin (SHBG) to the same degree, which can help manage the "free" androgen load more predictably.</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Practitioner Insight</span>
 <p>Always remind your clients that HRT is not a "magic pill." It works <em>best</em> when the metabolic foundation (The S.T.E.A.D.Y. Method‚Ñ¢) is already in place. HRT on top of uncontrolled insulin resistance is far less effective than HRT used to fine-tune a metabolically healthy body.</p>
 </div>

 <h2 id="sarcopenia">Sarcopenia Prevention: Activity & Muscle Activation (A)</h2>
 <p>Sarcopenia (age-related muscle loss) is the enemy of metabolic health. Muscle is the body‚Äôs largest <strong>"metabolic sink"</strong> for glucose. In the perimenopausal PCOS client, the loss of estrogen accelerates muscle breakdown.</p>

 <p>Our <strong>Activity & Muscle Activation (A)</strong> strategy must shift away from "burning calories" and toward "building tissue."</p>
 <ul>
 <li><strong>Resistance Training:</strong> Minimum of 3 days per week focusing on compound movements (squats, deadlifts, presses).</li>
 <li><strong>Intensity:</strong> Working at an RPE (Rate of Perceived Exertion) of 7-8 out of 10 to stimulate Muscle Protein Synthesis (MPS).</li>
 <li><strong>Recovery:</strong> Avoiding high-intensity interval training (HIIT) more than once a week to prevent HPA-axis overstimulation and chronic cortisol elevation.</li>
 </ul>

 <h2 id="cardio-risk">Cardiovascular Risk: Screening for the Future</h2>
 <p>The transition to menopause is the single greatest period of cardiovascular risk escalation for women with PCOS. We cannot rely on standard lipid panels (Total Cholesterol/LDL) alone. As a specialist, you must educate your clients on requesting advanced markers.</p>

 <p><strong>Key Markers to Monitor:</strong></p>
 <ul>
 <li><strong>Apolipoprotein B (ApoB):</strong> A more accurate measure of the total number of atherogenic particles than LDL-C.</li>
 <li><strong>Lipoprotein(a):</strong> A genetically determined marker that increases risk for early heart attack and stroke.</li>
 <li><strong>Hs-CRP:</strong> A marker of systemic inflammation (Detoxification & Inflammation Control - D).</li>
 <li><strong>HOMA-IR:</strong> To track the progression of insulin resistance.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">üí° Practitioner Insight</span>
 <p>Positioning yourself as a "Metabolic Longevity Specialist" allows you to work with high-net-worth clients who are invested in long-term health. Use these advanced markers to demonstrate your expertise and provide a level of care they won't find in a standard 15-minute primary care visit.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. What defines the "Androgen Tail" in perimenopausal PCOS?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans1')">Show Answer</button>
 <div id="ans1" class="answer-text">The Androgen Tail refers to the asymmetrical decline of hormones where estrogen and progesterone drop significantly, but androgens (testosterone/androstenedione) remain elevated, leading to a relative androgen dominance and a flare of symptoms like hair loss and acne.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Why is visceral adiposity a greater concern during this transition?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans2')">Show Answer</button>
 <div id="ans2" class="answer-text">The loss of estrogen's protective metabolic effects, combined with lifelong insulin resistance, causes fat to shift from the hips/thighs (subcutaneous) to the midsection (visceral), which is more inflammatory and increases cardiovascular risk.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which HRT option is generally preferred for managing the "E" in S.T.E.A.D.Y. for these clients?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans3')">Show Answer</button>
 <div id="ans3" class="answer-text">Bioidentical progesterone (Prometrium) and transdermal estrogen are preferred because they are chemically identical to human hormones, have fewer androgenic side effects, and bypass the liver's first-pass metabolism.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. Why should a PCOS specialist prioritize ApoB over standard LDL-C?</strong></p>
 <button class="reveal-btn" onclick="toggleAnswer('ans4')">Show Answer</button>
 <div id="ans4" class="answer-text">ApoB measures the actual number of atherogenic (plaque-forming) particles, which is a much more accurate predictor of cardiovascular risk in insulin-resistant populations than the total volume of cholesterol (LDL-C).</div>
 </div>
 </div>

 <div class="coach-tip">
 <span class="tip-label">üí° Practitioner Insight</span>
 <p>Success in this niche comes from <strong>reassurance</strong>. Many women in their late 40s feel like their bodies are "broken." By showing them the data and the physiological "why," you replace their fear with a functional roadmap. This is the hallmark of a premium specialist.</p>
 </div>

 <!-- Key Takeaways -->
 <div class="takeaways-box">
 <p class="box-label">Key Takeaways</p>
 <ul>
 <li>Perimenopause "unmasks" PCOS symptoms due to the relative dominance of the Androgen Tail.</li>
 <li>Therapeutic Glucose Tuning (T) must become more precise to combat the shift toward visceral fat.</li>
 <li>Bioidentical HRT can be a powerful tool for Endocrine Alignment (E) when used alongside metabolic foundations.</li>
 <li>Muscle is the primary defense against metabolic decline; prioritize resistance training over chronic cardio.</li>
 <li>Advanced cardiovascular screening (ApoB, Lp(a)) is non-negotiable for the aging PCOS client.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <p class="box-label">References & Further Reading</p>
 <ol>
 <li>Wild, S., et al. (2020). "Long-term health consequences of polycystic ovary syndrome." <em>Human Reproduction Update</em>.</li>
 <li>Schmidt, J., et al. (2021). "The menopausal transition in women with polycystic ovary syndrome: A 20-year follow-up." <em>Journal of Clinical Endocrinology & Metabolism</em>.</li>
 <li>Teede, H. J., et al. (2023). "Recommendations from the 2023 international evidence-based guideline for the assessment and management of PCOS." <em>Fertility and Sterility</em>.</li>
 <li>Greendale, G. A., et al. (2019). "Changes in body composition and weight during the menopause transition." <em>JCI Insight</em>.</li>
 <li>Morselli, L. L., et al. (2018). "Role of androgens in the regulation of insulin sensitivity and body fat distribution in women." <em>Current Opinion in Endocrinology & Diabetes</em>.</li>
 <li>Sniderman, A. D., et al. (2021). "Apolipoprotein B Particles and Cardiovascular Risk Prediction." <em>Circulation</em>.</li>
 </ol>
 </div>
</div>

<script>
function toggleAnswer(id) {
 const el = document.getElementById(id);
 if (el.style.display === 'block') {
 el.style.display = 'none';
 } else {
 el.style.display = 'block';
 }
}
</script>

</body>
</html>